The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Protein Phosphatase 2A Positively Regulates Ras Signaling by Dephosphorylating KSR1 and Raf-1 on Critical 14-3-3 Binding Sites
Open accessAbstract
Background Kinase Suppressor of Ras (KSR) is a conserved component of the Ras pathway that acts as a molecular scaffold to facilitate signal transmission through the MAPK cascade. Although recruitment of KSR1 from the cytosol to the plasma membrane is required for its scaffolding function, the precise mechanism(s) regulating the translocation of KSR1 have not been fully elucidated.Results Using mass spectrometry to analyze the KSR1-scaffolding complex, we identify the serine/threonine protein phosphatase PP2A as a KSR1-associated protein and show that PP2A is a critical regulator of KSR1 activity. We find that the enzymatic core subunits of PP2A (PR65A and catalytic C) constitutively associate with the N-terminal domain of KSR1, whereas binding of the regulatory PR55B subunit is induced by growth factor treatment. Specific inhibition of PP2A activity prevents the growth factor-induced dephosphorylation event involved in the membrane recruitment of KSR1 and blocks the activation of KSR1-associated MEK and ERK. Moreover, we find that PP2A activity is required for activation of the Raf-1 kinase and that both Raf and KSR1 must be dephosphorylated by PP2A on critical regulatory 14-3-3 binding sites for KSR1 to promote MAPK pathway activation.Conclusions These findings identify KSR1 as novel substrate of PP2A and demonstrate the inducible dephosphorylation of KSR1 in response to Ras pathway activation. Further, these results elucidate a common regulatory mechanism for KSR1 and Raf-1 whereby their localization and activity are modulated by the PP2A-mediated dephosphorylation of critical 14-3-3 binding sites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The three subunits of the PP2A/B55α holoenzyme were detected in immunopurified RAF1 by mass spectrometry and B55α recruitment to the RAF1-PP2A/AC complex was stimulated by PDGF, which stimulates RAF1-Ser259 dephosphorylation (Ory et al., 2003).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Ory et al., 2003
In the citing paper
“Upon PDGF treatment, PP2A/B55 dephosphorylates KSR1 on Ser392, which releases it from 14-3-3 and allows it to translocate to the cell membrane to facilitate MAPK pathway activation (Ory et al., 2003).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Ory et al., 2003
In the citing paper
“Kinase Suppressor of Ras 1 (KSR1), the molecular scaffold that assembles the MAPK pathway, is also a dephosphorylation target of PP2A, as mass spectrometry analysis identified the PP2A core dimer and B55α in immunopurified KSR1.”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Ory et al., 2003
In the citing paper
“In the MAPK pathway, PP2A/B family members B55α and B55δ dephosphorylate RAF1 on Ser259 (Adams et al., 2005; Ory et al., 2003), a residue that when phosphorylated inhibits RAF1 kinase by binding to 14-3-3 proteins (Abraham et al., 2000; Jaumot and Hancock, 2001).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Ory et al., 2003
Citations
Cites
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,927
Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry
Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T., & Mann, M. (1996) · Nature · doi:10.1038/379466a0 · Cited by 1,674
Organization and regulation of mitogen-activated protein kinase signaling pathways
Garrington, T. P., & Johnson, G. L. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80028-3 · Cited by 1,268
The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals
Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.455 · Cited by 1,123
Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARFPreprint
Jacobs, J. J. L., Scheijen, B., Voncken, J. W., Kieboom, K., Berns, A. J. M., & van Lohuizen, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2678 · Cited by 1,069
Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules
Verhey, K. J., Meyer, D., Deehan, R., Blenis, J., Schnapp, B. J., Rapoport, T. A., & Margolis, B. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.5.959 · Cited by 609
Sontag, E., Fedorov, S. A., Kamibayashi, C., Robbins, D. J., Cobb, M. H., & Mumby, M. C. (1993) · Cell · doi:10.1016/0092-8674(93)90533-v · Cited by 510
Ste5 tethers multiple protein kinases in the MAP kinase cascade required for mating in S. cerevisiae
Chol, K.-Y., Satterberg, B., Lyons, D. M., & Elion, E. A. (1994) · Cell · doi:10.1016/0092-8674(94)90427-8 · Cited by 502
Jacobs, D., Glossip, D., Xing, H., Muslin, A. J., & Kornfeld, K. (1999) · Genes & Development · doi:10.1101/gad.13.2.163 · Cited by 439
Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals
Whitmarsh, A. J., & Davis, R. J. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01309-7 · Cited by 387
Cited by
Sorted by citations
Items 201–299 of 299
Smolen, K. A., Papke, C. M., Swingle, M. R., Musiyenko, A., Li, C., Salter, E. A., Camp, A. D., Honkanen, R. E., & Kettenbach, A. N. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105154 · Cited by 17
Cinar, B., Al‐Mathkour, M. M., Khan, S. A., & Moreno, C. S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013794 · Cited by 17
Raf kinases in signal transduction and interaction with translation machinery
Migliaccio, N., Sanges, C., Ruggiero, I., Martucci, N. M., Rippa, E., Arcari, P., & Lamberti, A. (2013) · BioMolecular Concepts · doi:10.1515/bmc-2013-0003 · Cited by 17
Ossum, C. G., Wulff, T., & Hoffmann, E. K. (2006) · Journal of Experimental Biology · doi:10.1242/jeb.02152 · Cited by 17
Lee, J. A., Wang, Z., Sambo, D., Bunting, K. D., & Pallas, D. C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002012 · Cited by 16
Zhu, P., Wu, X., Ni, L., Chen, K., Dong, Z., Du, J., Kong, F., Mao, Y., Tao, H., Chu, M., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166888 · Cited by 16
Metabolic stress regulates ERK activity by controlling KSR‐RAF heterodimerization
Verlande, A., Krafčíková, M., Potěšil, D., Trantı́rek, L., Zdráhal, Z., Elkalaf, M., Trnka, J., Souček, K., Rauch, N., Rauch, J., et al. (2017) · EMBO Reports · doi:10.15252/embr.201744524 · Cited by 16
Cao, Q., Qian, M., Wang, X. F., Wang, B., Wu, H., Zhu, X., Wang, Y. W., & Guo, J. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0285-1 · Cited by 16
Kinase suppressor of Ras transphosphorylates c-Raf-1
Zafrullah, M., Yin, X., Haimovitz‐Friedman, A., FUKS, Z. Y., & Kolesnick, R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.048 · Cited by 16
Li, A. X., Martin, T. A., Lane, J., & Jiang, W. G. (2023) · Cancers · doi:10.3390/cancers16010076 · Cited by 15
Potential involvement of mi-RNA 574-3p in progression of prostate cancer: A bioinformatic study
Ashraf, N. M., Imran, K., Kastner, D. W., Ikram, K., Mushtaq, A., Hussain, A., & Zeeshan, N. (2017) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2017.07.002 · Cited by 15
Wang, H., Chi, L., Yu, F., Dai, H., Si, X., Gao, C., Wang, Z., Liu, L., Zheng, J., Ke, Y., et al. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116922 · Cited by 15
Regulation of Glucose Homeostasis by KSR1 and MARK2
Klutho, P. J., Costanzo-Garvey, D. L., & Lewis, R. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029304 · Cited by 15
Kawahara, E., Maenaka, S., Shimada, E., Nishimura, Y., & Sakurai, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063729 · Cited by 16
Wong, A. Y. W., Oikonomou, V., Paolicelli, G., LUCA, A. D., Pariano, M., Frič, J., Tay, H. S., Ricciardi‐Castagnoli, P., & Zelante, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00210 · Cited by 15
Ras‐Sensitive IMP Modulation of the Raf/MEK/ERK Cascade Through KSR1
Matheny, S. A., & White, M. A. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07020-5 · Cited by 15
Nemoto, S., Taguchi, K., Matsumoto, T., Kamata, K., & Kobayashi, T. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01128.2011 · Cited by 14
The CRAL/TRIO and GOLD domain protein TAP-1 regulates RAF-1 activation
Johnson, K. G., & Kornfeld, K. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.03.003 · Cited by 14
PRUNE1 and NME/NDPK family proteins influence energy metabolism and signaling in cancer metastases
Ferrucci, V., Lomada, S. K., Wieland, T., & Zollo, M. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10165-4 · Cited by 12
Fomo, K. N., Perumal, N., Manicam, C., Pfeiffer, N., & Grus, F. H. (2024) · Cells · doi:10.3390/cells13090775 · Cited by 13
Three distinct regions of cRaf kinase domain interact with membrane
Prakash, P., Hancock, J. F., & Gorfe, A. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-38770-w · Cited by 11
Schwarz, T. M., Murphy, S., Sohn, C., & Mansky, K. C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.034 · Cited by 11
Kinase Suppressor of Ras Couples Ras to the ERK Cascade during T Cell Development
Laurent, M. N., Ramirez, D. M., & Alberola‐Ila, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.986 · Cited by 11
Depletion of CLK2 sensitizes glioma stem-like cells to PI3K/mTOR and FGFR inhibitors.
Park, S. Y., Mittal, S., Dong, J., Jeong, K., Martínez-Ledesma, E., Piao, Y., Khan, S., Henry, V. K., Verhaak, R. G. W., Majd, N., et al. (2020) · PubMed Central · Cited by 10
Sibilski, C., Mueller, T. D., Kollipara, L., Zahedi, R. P., Rapp, U. R., Rudel, T., & Baljuls, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.490235 · Cited by 9
Survival of BRCA2-Deficient Cells Is Promoted by GIPC3, a Novel Genetic Interactor of BRCA2
Ding, X., Philip, S., Martin, B. K., Pang, Y., Burkett, S. S., Swing, D. A., Pamala, C., Ritt, D. A., Zhou, M., Morrison, D. K., et al. (2017) · Genetics · doi:10.1534/genetics.117.300357 · Cited by 9
Self-citationConvergent genetic aberrations in murine and human T lineage acute lymphoblastic leukemias
Huang, B. J., Wandler, A. M., Meyer, L. K., Dail, M., Daemen, A., Sampath, D., Li, Q., Wang, X., Wong, J. C. Y., Nakitandwe, J., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008168 · Cited by 8
A Raf-Competitive K-Ras Binder Can Fail to Functionally Antagonize Signaling
Kauke, M. J., Tisdale, A. W., Kelly, R. L., Braun, C. J., Hemann, M. T., & Wittrup, K. D. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0645 · Cited by 8
Gao, C., Wang, S., Lu, J., Chai, X., Li, Y.-C., Zhang, P., Huang, X., Cai, J., Zheng, Y.-M., Guo, X.-J., et al. (2022) · Biomarker Research · doi:10.1186/s40364-022-00361-9 · Cited by 7
Compensation effect of the MAPK cascade on formation of phospho-protein gradients
Naka, T., Okada, M., Sakamoto, N., & Konagaya, A. (2005) · Biosystems · doi:10.1016/j.biosystems.2005.06.015 · Cited by 7
Wang, L., Chen, X., Qu, R., Shao, S., Gong, L., Li, T., Jiang, S., Lu, Y., Ma, Y., Sun, Y. N., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218013 · Cited by 7
A comprehensive review of targeting RAF kinase in cancer
Hossain, M. A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177142 · Cited by 6
Selection on Network Dynamics Drives Differential Rates of Protein Domain Evolution
Mannakee, B. K., & Gutenkunst, R. N. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006132 · Cited by 6
Ivovič, D., Kabelíková, P., & Jurkovičová, D. (2023) · Neoplasma · doi:10.4149/neo_2023_230806n411 · Cited by 7
Proteomic Analysis of Scaffold Proteins in the ERK Cascade
McKay, M., & Morrison, D. K. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-795-2_19 · Cited by 6
Self-citationDíaz, R. G., Escudero, D. S., Brea, M. S., Morgan, P. E., & Pérez, N. G. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.01.070 · Cited by 6
Dynamic Coupling of MAPK Signaling to the Guanine Nucleotide Exchange Factor GEF-H1
Leguay, K., & Kent, O. A. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s496228 · Cited by 6
Phosphoregulation of the novel hemi-arrestin MAPK scaffold Sms1 prevents untimely mating
Sieber, B., Merlini, L., Li, W., Besomi, M., Michon, L., Gordon-Lennox, S., & Martin, S. G. (2026) · Nature Communications · doi:10.1038/s41467-026-70631-9 · Cited by 5
Effect of 14-3-3 tau protein on differentiation in BeWo choriocarcinoma cells
Cheng, Y., Hu, R. H., Jin, H., Ma, K., Zhou, S., Cheng, H., Ma, D., & Li, X. (2009) · Placenta · doi:10.1016/j.placenta.2009.10.002 · Cited by 5
Modulation of PP2A activity by Jacalin: is it through caveolae and ER chaperones?
Ahmed, N., Pany, S., Rahman, M. A., Srivastava, S. S., Sneh, A., & Krishnasastry, M. V. (2009) · Glycoconjugate Journal · doi:10.1007/s10719-009-9258-5 · Cited by 5
Madduri, L. S. V., Brandquist, N. D., Palanivel, C., Talmon, G. A., Baine, M. J., Zhou, S., Enke, C. A., Johnson, K. R., Ouellette, M. M., & Yan, Y. (2021) · Neoplasia · doi:10.1016/j.neo.2021.10.002 · Cited by 5
Molecular dissection on inhibition of Ras-induced cellular senescence by small t antigen of SV40
Shang, D., Zhou, T., Zhuang, X., Wu, Y., Liu, H., & Tu, Z. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04275-5 · Cited by 5
Zhao, J., Chen, G., Li, J., Liu, S., Jin, Q., Zhang, Z., Qi, F., Zhang, J., & Xu, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01796-0 · Cited by 5
Targeting Kinase Suppressor of Ras 1 (KSR1) for Cancer Therapy
Moon, H., Park, H., Lee, S., Lee, S.-H., & Ro, S. W. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101348 · Cited by 5
Denti, V., Greco, A., Alviano, A. M., Capitoli, G., Monza, N., Smith, A. J., Pilla, D., Maggioni, A., Ivanova, M. D., Venetis, K., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313115 · Cited by 4
Influence of Ginkgo biloba extract EGb 761 on signaling pathways in endothelial cells
Koltermann, A. (2008) · doi:10.5282/edoc.8079 · Cited by 4
Xu, C., Cheng, Y., Han, M., Tao, Y., & Liu, J. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03843-2 · Cited by 3
Caliva, M. J., Yang, W. S., Young‐Robbins, S. S., Zhou, M., Yoon, H., Matter, M. L., Grimes, M. L., Conrads, T. P., & Ramos, J. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-99348-z · Cited by 3
Self-citationSer/Thr Phosphatases: The New Frontier for Myeloid Leukemia Therapy?
Amanda, M., Kathryn, G., & Nicole, M. (2011) · InTech eBooks · doi:10.5772/26425 · Cited by 3
Kulkarni, M. M., & Perrimon, N. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385944-0.00005-8 · Cited by 3
RNA polymerase III transcription machinery: Structure and transcription regulation
Tv, N., & Tishchenko, L. I. (2005) · Molecular Biology · doi:10.1007/s11008-005-0024-x · Cited by 3
Kawahara, E., Maenaka, S., Shimada, E., Nishimura, Y., & Sakurai, H. (2013) · PLoS ONE · doi:10.1371/annotation/0c13510e-5537-49c0-906f-9cfa842f0363 · Cited by 3
Striatin (STRN): A multifunctional protein in cardiovascular health and cancer progression
Gholami, K., Sivakumar, A., Mohanraj, J., Farghadani, R., Hisham, S. H. A., Heydarpour, M., & Williams, G. H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118395 · Cited by 2
Proteomic applications in identifying protein-protein interactions
Veenstra, B. T., & Veenstra, T. D. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.04.001 · Cited by 2
Self-citationSignalling Pathways Operated by Receptor Protein Tyrosine Kinases
Gomperts, B. D., Kramer, I. M., & Tatham, P. E. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369441-6.00012-x · Cited by 2
Survival Regulation by Ras and Raf
Drexler, H. C. A., Galmiche, A., Hekman, M., Albert, Š., & Rapp, U. R. (2006) · Wiley eBooks · doi:10.1002/9783527619665.ch18 · Cited by 2
Jenkins, C. B., Camero, A. L., Graff, B. T., Madduri, L. S. V., O’Connell, K. A., Hein, A. L., Smith, L. M., Enke, C. A., Dong, J., Hollingsworth, M. A., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03477-y · Cited by 1
Cao, Y., Zhao, C., Li, J., Gao, Q., Lv, C., Wang, J., Qiang, N., Zhang, W., Su, H., Min, X., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05323-4 · Cited by 1
RAS and the RAF/MEK/ERK Cascade
Morrison, D. K., & Daar, I. O. (2006) · Springer eBooks · doi:10.1007/1-4020-4708-8_4 · Cited by 1
Self-citationRegulation of Cell Proliferation by Receptor Tyrosine Protein Kinases
Kramer, I. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394803-8.00010-3 · Cited by 1
Zhou, Y., & Hancock, J. F. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1806-1_9 · Cited by 1
A small molecule inhibitor of leucine carboxyl methyltransferase-1 inhibits cancer cell survival
Arosarena, O. A., Sarıbaş, A. S., & Papadopoulos, E. P. (2024) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2024.1278163 · Cited by 1
Characterization of Protein Complexes
Veenstra, T. D. (2013) · Wiley eBooks · doi:10.1002/9781118634493.ch5 · Cited by 1
Self-citationLipid binding and the scaffolding function of the Kinase Suppressor of Ras
Kraft, C. A. (2005) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Wasserman, J. S., Kurimchak, A., Herrera-Montávez, C., Doyle, G. A. R., Fox, B. D., Kodikara, I. K. M., Hu, X. P., Hu, J., Jin, J. J., & Duncan, J. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.11.642495 · Cited by 1
Acevedo, S. F. (2005) · OakTrust (Texas A&M University Libraries) · Cited by 1
Intracellular Signal Transduction Cascades
Matthews, D. J., & Gerritsen, M. E. (2010) · Wiley eBooks · doi:10.1002/9780470555293.ch5
Alteracions de la VIA RAS-RAF en càncer gastrointestinal amb defectes de reparació genòmica
Domingo, E. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Mitogen-Activated Protein Kinases and Their Scaffolding Proteins
Dhanasekaran, D. N., & Reddy, E. P. (2009) · Springer eBooks · doi:10.1007/978-3-642-02112-1_12
Progesterone as a regulator of phosphorylation in the central nervous system
Amorim, M. A. R., Guerra‐Araiza, C., & García‐Segura, L. M. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.056
Bissonnette, D. M. (2005) · eCommons (Cornell University)
The Role of Protein-Protein Interactions in the Activation Cycle of RAF Kinases
Würzburg, J.-M.-U. (2010)
Shaw, A. S., Lin, J., Harding, A. S., & Giurisato, E. (2014)
Shaw, A. S., Cella, M., Lewis, R. E., Colonna, M., Giurisato, E., Lin, J., & Harding, A. S. (2014)
The Role of the Rho GEF Arhgef2 in RAS Tumorigenesis
Cullis, J. E. (2013) · TSpace (University of Toronto)
Nanoclustering augmentation : a novel mechanism of Ras activation in cancer
Šolman, M. (2016) · Doria (University of Helsinki)
Xue, D., Hou, L. S., Zhang, S. R., & Chen, N. X. (2014) · Genetics and Molecular Research · doi:10.4238/2014.may.23.6
Hondermarck, H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00169-8 · Cited by 1
Activation of survival pathways triggered by death receptors in the nervous system
Fernández, F. M. (2013) · TDX (Tesis Doctorals en Xarxa)
Sharma, S. B. (2015) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6619
The Molecular Pathogenesis of Noonan Syndrome-Associated RAF1 Mutations
Wu, X. (2014) · TSpace (University of Toronto)
BAD Phosphorylation: A Novel Link between Apoptosis and Cancer
Polzien, L. (2011)
Roy, F. M. V. (2008) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1122828.579916
Robichaud, P. P., Bouhamdani, N., Girouard, E., Biden, E., & Amor, M. B. (2023) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-023-01084-z
Xu, H., Cai, Y., Yang, H., Li, S., Chen, P., Wei, Z., Wang, F., Wang, Z., & Zhang, Y. (2024) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2024.107457
Zhao, J., Chen, G., Li, J., Liu, S., Jin, Q., Zhang, Z., Qi, F., Zhang, J., & Xu, J. (2021) · Figshare · doi:10.6084/m9.figshare.14037694
Zhao, J., Chen, G., Li, J., Liu, S., Jin, Q., Zhang, Z., Qi, F., Zhang, J., & Xu, J. (2021) · Figshare · doi:10.6084/m9.figshare.14037691
Regulation of protein phosphatases in oxidatively stressed neurons
Ho, Y. (2007) · D-Scholarship@Pitt (University of Pittsburgh)
Etude phénotypique des cellules endométriosiques profondes
Leconte, M. (2012) · theses.fr (ABES) · doi:10.70675/6c60e34az6799z41eaz8bacz16682a3d37ea
Rôle et modes d'action de la Tétraspanine 8 dans l'invasion précoce du mélanome cutané
Kharbili, M. E. (2013) · theses.fr (ABES) · doi:10.70675/3e596898z95f7z4eb2za2aaz44ee31529d70
Cell penetrating and interfering peptides as new cancer therapy
Zhang, X. (2017) · theses.fr (ABES) · doi:10.70675/b2053021ze747z4f1azacb7z8a87a14ec9e3
Rôle de la kinase ARAF dans le mélanome cutané muté NRAS
Estrada, C. (2020) · theses.fr (ABES) · doi:10.70675/e84b4f6az1676z4c2dz80e4zd8668460d3c5
L'autophagie, cible thérapeutique potentielle dans les néoplasies myéloprolifératives JAK2V617F
Courdy, C. (2022) · theses.fr (ABES) · doi:10.70675/ac191938zdef5z44c8z9174z838011ac8d5c
Metadata
- Authors
- Ory, S., Zhou, M., Conrads, T. P., Veenstra, T. D., & Morrison, D. K.
- Affiliations
- Frederick National Laboratory for Cancer Research (US)
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Morrison, Deborah K
- Venue
- Current Biology
- Publisher
- Elsevier BV
- Published
- 2003-08
- Volume
- 13
- Issue
- 16
- Pages
- 1356-1364
- ISSN
- 0960-9822 (ISSN-L)
- OpenAlex
- W2166077873
- Cited by
- 296
- References
- 41
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 9 · 2020: 14 · 2019: 12 · 2018: 10 · 2017: 10 · 2016: 11 · 2015: 9 · 2014: 13 · 2013: 16 · 2012: 12
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Current Biology (publishedVersion)
- PubMed (publishedVersion)
- DigitalCommons-Cedarville (Cedarville University) (submittedVersion)
- HAL (submittedVersion)
- Funders
- U.S. Public Health Service (N01C012400)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- protein phosphatase 2A, KSR1, Raf-1, Ras signaling, MAPK signaling, dephosphorylation, membrane recruitment, MEK activation, ERK activation, growth factor signaling, scaffold proteins
- MeSH terms
- Amino Acid Sequence, Animals, Binding Sites, Enzyme Activation, Models, Biological, Molecular Sequence Data, Peptide Fragments, Phosphoprotein Phosphatases, Phosphorylation, Protein Kinases, Recombinant Proteins, Substrate Specificity, Tyrosine 3-Monooxygenase, Signal Transduction, 3T3 Cells, ras Proteins, COS Cells, Proto-Oncogene Proteins c-raf, MAP Kinase Signaling System, 14-3-3 Proteins, Mice, Protein Phosphatase 2, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review